Breaking News Instant updates and real-time market news.

AVEO

Aveo Pharmaceuticals

$2.53

-0.25 (-8.99%)

07:10
11/06/18
11/06
07:10
11/06/18
07:10

Aveo Pharmaceuticals price target raised to $9 from $6.50 at H.C. Wainwright

H.C. Wainwright analyst Swayampakula Ramakanth raised his price target for Aveo Pharmaceuticals to $9 saying the company announced positive topline results from the Phase 3 TIVO-3 study investigating the use of tivozanib for the treatment of refractory renal cell carcinoma. The analyst views the results as "very promising" and believes tivozanib still has "ample opportunity" to show a superior overall survival benefit. He believes the drug is on track for approval in 2020 and keeps a Buy rating on Aveo Pharmaceuticals.

  • 27

    Nov

AVEO Aveo Pharmaceuticals
$2.53

-0.25 (-8.99%)

08/16/18
08/16/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Post Holdings (POST) initiated with an Overweight at Piper Jaffray. 2. Stryker (SYK) initiated with a Buy at BTIG. 3. Aveo Pharmaceuticals (AVEO) initiated with a Buy at H.C. Wainwright. 4. Uxin (UXIN) initiated with a Buy at Goldman Sachs. 5. AcelRx (ACRX) initiated with a Buy at Ladenburg. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
10/01/18
PIPR
10/01/18
NO CHANGE
Target $5
PIPR
Overweight
Piper remains confident in Aveo reporting positive TIVO-3 data
After an Independent Steering Committee recommended the initiation of top-line analysis of Aveo Pharmaceuticals' Phase 3 TIVO-3 trial of tivozanib in third-line renal cell carcinoma, Piper Jaffray analyst Edward Tenthoff noted that the lower than expected event rate of 242 events "minimally reduces" powering of the trial to 88% from the originally planned for 90%, but he remains confident in positive top-line TIVO-3 data being reported in about 6 weeks. Tenthoff reiterates his Overweight rating and $5 price target on Aveo shares.
10/22/18
PIPR
10/22/18
NO CHANGE
Target $5
PIPR
Overweight
TiNivo data competitively position Aveo Pharmaceuticals, says Piper Jaffray
Piper Jaffray analyst Edward Tenthoff believes the data for tivozanib combined with Opdivo to treat metastatic renal cell carcinoma presented at the ESMO meeting competitively position Aveo Pharmaceuticals as the treatment landscape for front-line RCC moves to I-O and TKI combinations. An ORR of 56% and DCR of 96% represent "promising early activity," said Tenthoff., who reiterates his Overweight rating and $5 target on Aveo shares.
11/05/18
PIPR
11/05/18
NO CHANGE
Target $5
PIPR
Overweight
Aveo Pharmaceuticals tivozanib's initial sales seen at $27M, says Piper Jaffray
Piper Jaffray analyst Edward Tenthoff kept his Overweight rating and $5 price target on Aveo Pharmaceuticals after its announcement this evening that the phase 3 TIVO-3 trial of tivozanib vs. Nexavar in 3rd line renal cell carcinoma met its primary endpoint target. The analyst expects the company to file a New Drug Application for tivozanib in the next 6 months, and after its expected approval, he estimates that the initial 2020 sales will be around $27M before reaching about $189M in 2025. Tenthoff adds that based on the data, there is further opportunity for tivozanib use in compbination with Opdivo.

TODAY'S FREE FLY STORIES

STIM

Neuronetics

$18.01

0.59 (3.39%)

07:55
02/19/19
02/19
07:55
02/19/19
07:55
Conference/Events
Neuronetics management to meet with Piper Jaffray »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 20

    Feb

CTL

CenturyLink

$13.73

0.96 (7.52%)

07:54
02/19/19
02/19
07:54
02/19/19
07:54
Upgrade
CenturyLink rating change  »

CenturyLink upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 11

    Mar

ORPN

Bio Blast Pharma

$1.19

0.05 (4.39%)

, SEEL

Seelos Therapeutics

$3.64

-0.27 (-6.91%)

07:52
02/19/19
02/19
07:52
02/19/19
07:52
Hot Stocks
Bio Blast Pharma announces sale of Trehalose clinical development programs »

Bioblast Pharma (ORPN)…

ORPN

Bio Blast Pharma

$1.19

0.05 (4.39%)

SEEL

Seelos Therapeutics

$3.64

-0.27 (-6.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SDVKY

Sandvik AB

$0.00

(0.00%)

07:52
02/19/19
02/19
07:52
02/19/19
07:52
Conference/Events
Sandvik AB management to meet with Jefferies »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 23

    May

NCS

NCI Building

$7.66

-0.11 (-1.42%)

07:50
02/19/19
02/19
07:50
02/19/19
07:50
Downgrade
NCI Building rating change  »

NCI Building downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Walmart

$100.00

1.52 (1.54%)

07:49
02/19/19
02/19
07:49
02/19/19
07:49
Hot Stocks
Walmart raises annual dividend to $2.12 per share from $2.08 per share »

The board of Walmart…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 03

    Mar

  • 06

    Mar

PRU

Prudential

$93.16

2.49 (2.75%)

07:48
02/19/19
02/19
07:48
02/19/19
07:48
Conference/Events
Prudential management to meet with Sandler O'Neill »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 05

    Jun

NSC

Norfolk Southern

$182.88

1.05 (0.58%)

07:48
02/19/19
02/19
07:48
02/19/19
07:48
Downgrade
Norfolk Southern rating change  »

Norfolk Southern cut to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

UNIT

Uniti Group

$20.00

0.53 (2.72%)

, WIN

Windstream

$3.37

0.2 (6.31%)

07:46
02/19/19
02/19
07:46
02/19/19
07:46
Downgrade
Uniti Group, Windstream rating change  »

Uniti Group downgraded to…

UNIT

Uniti Group

$20.00

0.53 (2.72%)

WIN

Windstream

$3.37

0.2 (6.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 28

    Feb

  • 11

    Mar

BBD

Banco Bradesco

$12.40

0.07 (0.57%)

07:46
02/19/19
02/19
07:46
02/19/19
07:46
Conference/Events
Banco Bradesco management to meet with JPMorgan »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 20

    Feb

  • 22

    Feb

  • 22

    Feb

PCG

PG&E

$15.50

0.02 (0.13%)

07:46
02/19/19
02/19
07:46
02/19/19
07:46
Upgrade
PG&E rating change  »

PG&E upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBLX

Noble Midstream

$32.09

-0.04 (-0.12%)

07:45
02/19/19
02/19
07:45
02/19/19
07:45
Hot Stocks
Breaking Hot Stocks news story on Noble Midstream »

Noble Midstream sees FY19…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

07:45
02/19/19
02/19
07:45
02/19/19
07:45
General news
Global Risks Ebb and Flow: »

Global Risks Ebb and…

XPO

XPO Logistics

$52.01

-7.535 (-12.65%)

07:44
02/19/19
02/19
07:44
02/19/19
07:44
Recommendations
XPO Logistics analyst commentary  »

XPO Logistics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

NBLX

Noble Midstream

$32.09

-0.04 (-0.12%)

07:43
02/19/19
02/19
07:43
02/19/19
07:43
Hot Stocks
Noble Midstream sees FY19 capital budget $335M-$375M »

Noble Midstream's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

NBLX

Noble Midstream

$32.09

-0.04 (-0.12%)

07:42
02/19/19
02/19
07:42
02/19/19
07:42
Hot Stocks
Noble Midstream sees adjusted EBITDA from partnership of at least $300M in 2020 »

Anticipates adjusted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

CSX

CSX

$72.52

0.91 (1.27%)

07:41
02/19/19
02/19
07:41
02/19/19
07:41
Downgrade
CSX rating change  »

CSX downgraded to Sector…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 28

    May

HEXO

HEXO Corp

$5.57

0.17 (3.15%)

07:40
02/19/19
02/19
07:40
02/19/19
07:40
Initiation
HEXO Corp initiated  »

HEXO Corp initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WIN

Windstream

$3.37

0.2 (6.31%)

07:40
02/19/19
02/19
07:40
02/19/19
07:40
Downgrade
Windstream rating change  »

Windstream downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

AMSC

AMSC

$15.00

-0.8 (-5.06%)

07:40
02/19/19
02/19
07:40
02/19/19
07:40
Conference/Events
AMSC management to meet with Roth Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 20

    Feb

NBLX

Noble Midstream

$32.09

-0.04 (-0.12%)

07:40
02/19/19
02/19
07:40
02/19/19
07:40
Hot Stocks
Noble Midstream sees FY19 adjusted EBITDA $340M-$390M »

"Entering 2019, we…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

07:40
02/19/19
02/19
07:40
02/19/19
07:40
General news
Treasury Market Outlook: bond yields have dipped slightly lower amid risk-off flows »

Treasury Market Outlook:…

CEQP

Crestwood Equity

$32.82

-0.06 (-0.18%)

07:39
02/19/19
02/19
07:39
02/19/19
07:39
Earnings
Crestwood Equity sees FY19 net income $105M-$135M »

Sees FY 19 adjusted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

PODD

Insulet

$88.51

3.68 (4.34%)

07:38
02/19/19
02/19
07:38
02/19/19
07:38
Recommendations
Insulet analyst commentary  »

Insulet price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

NWL

Newell Brands

$17.15

-4.55 (-20.97%)

07:38
02/19/19
02/19
07:38
02/19/19
07:38
Recommendations
Newell Brands analyst commentary  »

Newell Brands price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.